Physician profile
Avinash Singh
NPI 1043763832
$2,208.06
in general payments reported to CMS, 2019-2025
13 companies · $735 in 2025
The $735 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $124 · 2023: $683 · 2024: $666 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.53 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $490.64 | 2023-2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $372.56 | 2022-2025 | Tezspire, Fasenra |
| Abiomed | $268.12 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $266.03 | 2023-2024 | |
| Boston Scientific Corporation | $228.60 | 2025 | Rotablator Rotational Atherectomy System Console Kit, Baylis Medical Company Radiofrequency Puncture Generator |
| Insmed, INC. | $167.65 | 2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.86 | 2025 | Ofev |
| Biotronik INC. | $86.03 | 2023 | Amvia Edge |
| Lilly USA, LLC | $76.77 | 2025 | Zepbound, Mounjaro |
| Impulse Dynamics (USA) INC. | $52.83 | 2023 | Optimizer |
| Inari Medical, INC. | $39.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Viatris Specialty LLC | $22.43 | 2025 | Yupelri |
| Medtronic, INC. | $17.22 | 2024 | Cobalt Dr Mri Surescan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.